Exosome Sciences, Inc., in collaboration with majority shareholder Aethlon Medical, Inc. and investigators at Boston University and the University of Washington, announced today the published preliminary results of possibly the first blood test to detect the neurodegenerative disease, Chronic Traumatic Encephalopathy (CTE) during life.
from Dementia Big http://ift.tt/1QZalmT
via Stopping Dementia
from WordPress http://ift.tt/1M2xIe4
via alcoholic dementia
http://ift.tt/1TDXyx3
No comments:
Post a Comment